Baseline demographic and health characteristics of the overall 2001 cohort of new users of acid suppression therapy, by type of acid suppressant at time of cohort entry, and those who were ever exposed to PPI.
Overall cohort
New users of H2 Blockers at time of cohort entry New users of PPI at time of cohort entry a. Includes patients exposed to PPI at T0 (n=275977) and during follow-up (n=33136). Variables were measured at time of PPI exposure. b. P value for difference between exposed to H2 at T0 and exposed to PPI at T0 
